Friday 6 November 2026 Export HLN’s income statement to Excel — free account

Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%

Follow HLN

Alert me

Market cap: $40.2B
P/E: 20.5×
Fwd P/E: 16.5×
Dividend yield: 2.16%
F-score: 8/9
Altman Z: 3.04
Beneish M: −2.60
Dividend safety: 63/100

Overview

Haleon PLC Sponsored ADR (HLN) Current ratio

Alert me on Current ratio

Haleon PLC Sponsored ADR's current ratio at the end of the quarter to 30 June 2026 was 0.7×, down 0.2× from fiscal 2025 (0.9×). Over the past ten years it has ranged from 0.9× (fiscal 2025) to 1.4× (fiscal 2019) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/HLN/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Haleon PLC Sponsored ADR current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/HLN/metrics/current-ratio">Haleon PLC Sponsored ADR (HLN) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	0.9×	(6.24%)
FY2024	1.0×	(5.26%)
FY2023	1.0×	11.80%
FY2022	0.9×	(25.04%)
FY2021	1.2×	(0.69%)
FY2020	1.2×	(8.35%)
FY2019	1.4×	—

Period	Current ratio	Change
Jun 2026	0.7×	(21.00%)
Jun 2025	0.9×	3.87%
Jun 2024	0.8×	(0.61%)
Jun 2023	0.8×	(9.28%)
2 more quarters	Free account

Against its own ten years

Low 0.9× High 1.4×

Ten-year median 1.0×

Current reading's percentile 14

Company	Current ratio
UTHR United Therapeutics Corporation compare	4.7×
ZTS Zoetis Inc. compare	3.1×
ELAN Elanco Animal Health Incorporated compare	2.1×
NBIX Neurocrine Biosciences, Inc. compare	2.0×
RDY Dr. Reddy's Laboratories Ltd compare	1.9×
VTRS Viatris Inc. compare	1.6×
TAK Takeda Pharmaceutical Co. compare	1.2×
TEVA Teva Pharmaceutical Industries Ltd. compare	0.9×
HLN Haleon PLC Sponsored ADR	0.7×
Drug Manufacturers Specialty & Generic industry median	2.4×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Haleon PLC Sponsored ADR (HLN) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on HLN

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on HLN

Stockrow Weekly